Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden.
Pharma and biotech companies are breathing a sigh of relief after the reciprocal tariffs announced by President Donald Trump ...
In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s ...
23h
Singapore Business Review on MSNGIC, Temasek to acquire ‘significant stake’ in biotech CRO NovotechNovotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire “a significant stake” in Novotech, a biotech specialist clinical research ...
Singapore—a major chip manufacturing hub—has in recent years been attracting new investments from global semiconductor ...
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...
DUSSELDORF, Germany] DHL said on Monday (Mar 31) it will acquire US pharmaceutical logistics firm Cryopdp as part of the ...
It is financing Healthcare Advanced Synthesis’ acquisition of Cerbios-Pharma and taking a 40 per cent stake in merged entity.
Netanyahu reverses decision on new Israel security chief: office. Beirut (AFP) \| 01/04/2025 - 07:16:14 \| Lebanon president slams Israeli ...
Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s ...
We think SPH is in a good financial position. In the past three years, its debt over capital has been stable at around 0.4 times. Despite not being in a net cash position, it has enough cash to ...
Hi, it’s Elffie Chew in Singapore, where I’ve been chatting with investment bankers about deals in Southeast Asia and how the hub is holding up well despite challenges across the region. Also today, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results